Date: Apr 4, 2017

New CE Mark for WOUNDCHEK™ Bacterial Status


New! CE Mark for wounchek Bacterial Status
 
   

WOUNDCHEK™ Bacterial Status

Use in chronic wounds for earlier detection of bacterial pathogenicity from the most common bacterium in non-healing wounds1

✔ Identify wound infections before you can see them
•   Approximately 45%2 of chronic wounds have elevated bacterial protease activity indicative of bacterial pathogenesis, even in the absence of observable signs
   
✔ Treat bacterial infections appropriately
•   Clear diagnosis to support use of antimicrobials
Woundchek Bacterial Status

Not yet available in many countries, including the USA

 
 
     
Woundchek Protease Status

Not yet available in many countries, including the USA

 

WOUNDCHEK™ Protease Status

Use in non-healing wounds where infection has been treated or excluded

✔ Identify whether a chronic inflammatory response is preventing wound healing
•   Approximately 22% of non-healing, chronic wounds have elevated human protease activity
   
✔ Treat chronic inflammation for better wound healing
•   Protease modulating therapy breaks the cycle of stalled wound healing due to elevated human proteases
   
✔ CE mark since 2012
   
 
 
 
 
 

To learn more contact Brian Conibere or for general inquiries contact info@woundchek.com

360006

WOUNDCHEK™ Bacterial Status Test Pack; 6 Tests (all materials needed)


350012

WOUNDCHEK™ Protease Status Test Kit; 12 Tests (all materials needed)


For more information, visit www.woundchek.com

REFERENCES: 1. Gardner SE, Frantz RA. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs. 2008;10(1):44-53. 2. Estimate based on clinical trial data on file and Serena TE, Bayliff S, Brosnan P. Poster presented at Wounds UK; Novermber 14-16, 2015; Harrogate.

© 2017 WOUNDCHEK LABORATORIES

 
 
New! CE Mark for wounchek Bacterial Status
 
   

WOUNDCHEK™ Bacterial Status

Use in chronic wounds for earlier detection of bacterial pathogenicity from the most common bacterium in non-healing wounds1

✔ Identify wound infections before you can see them
•   Approximately 45%2 of chronic wounds have elevated bacterial protease activity indicative of bacterial pathogenesis, even in the absence of observable signs
   
✔ Treat bacterial infections appropriately
•   Clear diagnosis to support use of antimicrobials
Woundchek Bacterial Status

Not yet available in many countries, including the USA

 
 
     
Woundchek Protease Status

Not yet available in many countries, including the USA

 

WOUNDCHEK™ Protease Status

Use in non-healing wounds where infection has been treated or excluded

✔ Identify whether a chronic inflammatory response is preventing wound healing
•   Approximately 22% of non-healing, chronic wounds have elevated human protease activity
   
✔ Treat chronic inflammation for better wound healing
•   Protease modulating therapy breaks the cycle of stalled wound healing due to elevated human proteases
   
✔ CE mark since 2012
   
 
 
 
 
 

To learn more contact Brian Conibere or for general inquiries contact info@woundchek.com

360006

WOUNDCHEK™ Bacterial Status Test Pack; 6 Tests (all materials needed)


350012

WOUNDCHEK™ Protease Status Test Kit; 12 Tests (all materials needed)


For more information, visit www.woundchek.com

REFERENCES: 1. Gardner SE, Frantz RA. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs. 2008;10(1):44-53. 2. Estimate based on clinical trial data on file and Serena TE, Bayliff S, Brosnan P. Poster presented at Wounds UK; Novermber 14-16, 2015; Harrogate.

© 2017 WOUNDCHEK LABORATORIES

 
 

Close